Royce & Associates’s Hydrogenics Corp HYGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-169,295
Closed -$1.11M 1137
2016
Q3
$1.11M Sell
169,295
-111,000
-40% -$696K 0.01% 916
2016
Q2
$1.93M Sell
280,295
-136,000
-33% -$1.09M 0.01% 812
2016
Q1
$3.4M Hold
416,295
0.02% 708
2015
Q4
$3.65M Buy
416,295
+150,000
+56% +$1.46M 0.02% 710
2015
Q3
$2.15M Sell
266,295
-36,000
-12% -$315K 0.01% 854
2015
Q2
$3.07M Hold
302,295
0.01% 854
2015
Q1
$3.42M Hold
302,295
0.01% 831
2014
Q4
$4.02M Hold
302,295
0.01% 826
2014
Q3
$5.09M Sell
302,295
-129,705
-30% -$2.65M 0.02% 813
2014
Q2
$8.07M Buy
432,000
+225,000
+109% +$4.18M 0.02% 739
2014
Q1
$5.64M Buy
+207,000
New +$5.14M 0.02% 848

Other funds holding HYGS

Royce & Associates's HYGS Position: Q4 2016 in Review

Royce & Associates sold out of Hydrogenics Corp (HYGS) in Q4 2016, closing a stake of 169,295 shares — an estimated $1.11M sold.

Royce & Associates first reported a position in HYGS in Q1 2014 and held it in 11 quarters. The position peaked at $8.07M in Q2 2014. 29 funds tracked by Wall St. Rank hold HYGS as of Q4 2016.

  • Royce & Associates reported no remaining Hydrogenics Corp position as of Q4 2016 after selling out during the quarter.
  • Royce & Associates sold 169,295 Hydrogenics Corp shares in Q4 2016, an estimated $1.11M.
  • Royce & Associates first reported a position in Hydrogenics Corp in Q1 2014 and held it in 11 quarters.
  • Royce & Associates's Hydrogenics Corp position peaked at $8.07M in Q2 2014.
  • 29 funds tracked by Wall St. Rank held Hydrogenics Corp as of Q4 2016.

Based on Royce & Associates's 13F filing for Q4 2016, filed 10 Feb 2017.